1 | Transglutaminase | 80146-85-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
2 | Quinolinium Dichromate | 56549-24-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
3 | Propoxyethylene | 764-47-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
4 | ETHYL LAUROYL ARGINATE HCL | 60372-77-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
5 | Methyl 1H-indazole-5-carboxylate | 473416-12-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
6 | (1H-INDAZOL-3-YL)-ACETIC ACID | 26663-42-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
7 | 1H-Indole-6-acetic acid | 39689-58-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
8 | Ethyl indole-4-carboxylate | 50614-84-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
9 | Methyl indolyl-3-glyoxylate | 18372-22-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
10 | 1H-indole-3-propylamine | 6245-89-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
11 | Indole-2-carboxylic acid methyl ester | 1202-04-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
12 | Isoquinoline-5-carboxylic acid | 27810-64-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
13 | Isoquinoline-5-carboxaldehyde | 80278-67-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
14 | Isoquinoline-5-sulphonyl chloride hydrochloride | 105627-79-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
15 | Isoquinoline-4-carbaldehyde | 22960-16-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
16 | 3-isoquinolinecarbonitrile | 26947-41-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
17 | Methyl 3-isoquinolinecarboxylate | 27104-73-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
18 | mequindox | 13297-17-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
19 | Acetylacetonatobis(2-phenylpyridine)iridium | 337526-85-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
20 | ethyl 4-oxocyclohexaneacetate | 58012-34-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
21 | Ethyl 2,4-dihydroxy-6-methyl-3-pyridinecarboxylate | 70254-52-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
22 | Ethanone,2-amino-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-hydrochloride(1:1) | 1044764-21-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
23 | 1,1-Diethyl-4,4-Bipyridinium Diperchlorate | 36305-51-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
24 | Ethyl quinuclidine-4-carboxylate | 22766-68-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
25 | Ethyl Orange | 13545-67-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
26 | ETHYL 2-CHLORO-3-CYANO-6-METHYLISONICOTINATE | 40108-12-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
27 | Ethyl 2,4-dimethylnicotinate | 37669-78-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
28 | Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside | 130539-43-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
29 | ethyl 2-(4,6-dichloropyrimidin-2-yl)acetate | 63155-10-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
30 | biotinylamidoethylacetamide | 111790-37-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
31 | 2-ETHYLHEXYL DIPHENYL PHOSPHITE | 15647-08-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
32 | HEMATOPORPHYRIN | 14459-29-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
33 | (4-bromophenyl)(indolin-7-yl)methanone | 91714-41-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
34 | 2-BROMO-1-(3,4-DIMETHOXYPHENYL)ETHANONE | 1835-02-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
35 | Thymine-1-acetic acid | 20924-05-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
36 | Coumarin 6H | 58336-35-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
37 | 3-(benzothiazol-2-yl)-7-(diethylamino)-2-benzopyrone | 38215-36-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
38 | 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-(1)benzopyropyrano(6,7-8-I,j)quinolizin-11-one | 155306-71-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
39 | L-Ascorbate-2-phosphate | 23313-12-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
40 | Carbonylchlorohydrido[6-(di-t-butylphosphinomethyl)-2-(N,N-diethylaminomethyl)pyridine]ruthenium(II), min. 98% (Milstein Catalyst Precursor) | 863971-62-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
41 | tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu | 1118767-16-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
42 | 1,1-Dioxo-tetrahydro-thiopyran-4-one | 17396-35-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
43 | TERT-BUTYL TETRAHYDROPYRIMIDINE-1(2H)-CARBOXYLATE | 867065-85-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
44 | (TETRAHYDRO-FURAN-3-YL)-ACETIC ACID | 138498-97-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
45 | Tetrahydropyran-4-yl-acetic acid | 85064-61-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
46 | (Tetrahydro-2H-pyran-4-yl)hydrazine hydrochloride (1:2) | 1187974-47-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
47 | 2-phenyldihydro-2H-pyran-4(3H)-one | 147688-62-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
48 | (tetrahydro-pyran-4-yl)-hydrazine hydrochloride | 194543-22-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
49 | TETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID | 873397-34-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
50 | 2,4,6,8-TETRACHLOROPYRIMIDO[5,4-D]PYRIMIDINE | 32980-71-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
51 | 2,3,4,5-Tetraphenylthiophene | 1884-68-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
52 | 4,4',4'',4'''-methanetetrayltetrabenzoic acid | 160248-28-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
53 | Cis-Bis-(2,2-Bipyridine)Dichlororuthenium(II) Dihydrate | 15746-57-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
54 | cis-5-Methyl-1H-hexahydropyrrolo[3,4-b]pyrrole | 876130-70-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
55 | cis-4-Aminocyclohexanol | 40525-78-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
56 | Cis-2-(Tert-Butoxycarbonylamino)-1-Cyclopentanecarboxylic Acid, | 136315-70-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
57 | 3,4-Bis(3-indolyl)maleimide | 119139-23-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
58 | dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate | 1459-96-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
59 | Bis[4-(9,9-diMethyl-9,10-dihydroacridine)phenyl]solfone | 1477512-32-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
60 | Bis[2-(4,6-difluorophenyl)pyridinato-C2,N](picolinato)iridium(III) | 376367-93-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
61 | bis(3-Methoxyphenyl)aMine | 92248-06-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
62 | Di-2-Thienyl Ketone | 704-38-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
63 | bis-tris hydrochloride | 124763-51-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
64 | bis(2-methoxyphenyl)-oxophosphanium | 71360-04-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
65 | Bis(2,4,6-trimethylpyridine)iodine(I) hexafluorophosphate | 113119-46-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
66 | 7-AMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER | 171049-41-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
67 | TERT-BUTYL 3-BROMOMETHYL-INDOLE-1-CARBOXYLATE | 96551-21-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
68 | tert-butyl 8-oxo-3-azabicyclo[3.2.1]octane-3-carboxylate | 637301-19-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
69 | CHROMONE-3-CARBOXALDEHYDE | 17422-74-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
70 | Chromone-3-Carbonitrile | 50743-17-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
71 | Tosylate of Triethylene glycol monobenzyl ether | 84131-04-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
72 | [p-Terphenyl]-4,4''-dicarboxylic acid | 13653-84-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
73 | Tributyl(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)stannane | 175922-79-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
74 | Tris(2,4,6-triMethyl-3-(pyridin-3-yl)phenyl)borane | 929203-02-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
75 | Tris[2-(p-tolyl)pyridine]iridiuM(III) | 149005-33-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
76 | Tri(pyridin-4-yl)amine | 153467-50-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
77 | [Ru(bpm)3][Cl]2 | 65034-88-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
78 | Tris (2- (3-tert-butylphenyl) -4-tert-butylpyridine) iridium | 1311386-93-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
79 | THIAZOLE ORANGE | 107091-89-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
80 | 5-Thiazolecarboxylic acid, ethyl ester | 32955-22-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
81 | tianeptine sulfate | 1224690-84-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
82 | Thieno[3,2-b]thiophene-2,5-dicarboxaldehyde | 37882-75-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
83 | THIENO(3 2-B)PYRIDIN-7-OL | 107818-20-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
84 | Thieno[2,3-d]pyrimidin-4(3H)one | 14080-50-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
85 | Thiophene-2-thiocarboxamide | 20300-02-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
86 | N'-hydroxythiophene-2-carboximidamide | 53370-51-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
87 | Daphnetin 7-methyl ethe | 19492-03-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
88 | MAGNESIUM OROTATE | 34717-03-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
89 | PERFLUOROPOLYALKYL ETHER | 60164-51-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
90 | [Ethyl cyano(hydroxyimino)acetato-O2]tri-1-pyrrolidinylphosphonium hexafluorophosphate | 153433-21-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
91 | Soybean oil, hydrogenated | 8016-70-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
92 | OXY-PYRION 1-HYDROXY-2(1H)-PYRIDINONE SPECIALITY CHEMICALS | 822-89-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
93 | Hydroxybenzoquinoline | 33155-90-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
94 | HEPTAETHYLENE GLYCOL Monobenzyl ether | 423763-19-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
95 | PIPERAZINE DIHYDROCHLORIDE | 142-64-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
96 | Piperazine Dihydriodide | 58464-47-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
97 | Methyl piperazine-1-carboxylate | 50606-31-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
98 | 4-(Phenylazo)benzoic Acid | 1562-93-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
99 | Pyrimidine-5-boronic acid pinacol ester | 321724-19-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
100 | PYRIMIDIN-4-OL | 542-27-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
101 | Pyrimidinen-oxide | 17043-94-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
102 | Imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI) | 160911-42-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
103 | IMidazo [1,2-B] pyrazin-3 - carboxylic acid ethyl ester | 1286754-14-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
104 | Imidazo[1,2-a]pyridine-8-carboxylic acid, methyl ester | 133427-07-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
105 | imidazo[1,2-a]pyridin-8-amine | 73221-18-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
106 | Methyl imidazo[1,2-a]pyridine-7-carboxylate | 86718-01-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
107 | Imidazo[1,2-a]pyridine-7-carboxaldehyde | 136117-73-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
108 | 6-(Hydroxymethyl)imidazo[1,2-a]pyridine | 132213-07-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
109 | Imidazo[1,2-a]pyridin-5-amine | 66358-23-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
110 | NSC 304613 | 210035-02-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
111 | 2-imidazo[1,2-a]pyridin-2-ylacetic acid | 19741-30-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
112 | Ethyl imidazo[1,2-a]pyrimidine-2-carboxylate | 64951-06-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
113 | Imidazo[1,5-a]pyridine-8-carboxylic acid (9CI) | 697739-13-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
114 | IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID | 139022-25-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
115 | Ethyl Imidazo[1,2-a]pyridine-3-carboxylate | 123531-52-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
116 | IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE | 118000-43-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
117 | Meconin | 569-31-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
118 | Maxacalcitol | 103909-75-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
119 | Mal-PEG4-acid | 518044-41-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
120 | Tetradecyl Pyridinium Chloride | 2785-54-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
121 | Chloro[2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino))-1,1'-biphenyl]gold(I) | 1196707-11-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
122 | Chloro(tetrahydrothiophene)gold(I) | 39929-21-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
123 | Spectinomycin sulfate tetrahydrate | 64058-48-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
124 | quipazine | 4774-24-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
125 | Quinaldic acid | 93-10-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
126 | METHYL 6-QUINOLINEACETATE | 5622-36-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
127 | quinoline-6-carbonitrile | 23395-72-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
128 | quinoline-4-carboxylic acid | 486-74-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
129 | Quinoline-4-carbonitrile | 2973-27-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
130 | quinoline-2-carboxiMidaMide hydrochloride | 110177-05-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
131 | Inabenfide | 82211-24-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
132 | 9H-Carbazole, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- | 855738-89-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
133 | poly-4-dioxan-2-one | 29223-92-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
134 | Methyl 2-[(tert-butoxycarbonyl)amino]-3-nitrobenzoate | 57113-90-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
135 | Methoxymethylaminopyridine | 88569-83-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
136 | Methylethoxyquinoline | 6628-28-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
137 | 1-methylpiperazine dihydrochloride | 34352-59-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
138 | methylammonium iodide | 14965-49-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
139 | N-Succinimidyl Methacrylate | 38862-25-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
140 | Methyl 6-aminonicotinate | 36052-24-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
141 | Methyl-2,3-O-isopropylidene-D-ribofuranoside | 72402-14-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
142 | Methyl 2-(bromomethyl)-4-nitrobenzoate | 133446-99-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
143 | 1H-Pyrrolo[2,3-B]Pyridine-5-Carboxylic Acid Methyl Ester | 849067-96-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
144 | (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxymethyl)-2-methoxy-2H-pyran-3,4,5-triol | 1279691-36-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
145 | Sulfadimethoxine sodium salt | 1037-50-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
146 | CYCLOPENTANE-1,2-DICARBOXYLIC ACID ANHYDRIDE | 35878-28-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
147 | Xanthotol | 2009-24-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
148 | Silicic acid (H4SiO4),aluminum magnesium salt (2:2:1) | 12511-31-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
149 | BENZYL-D7 BROMIDE | 35656-93-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
150 | 2-bromo-1-(4-morpholinophenyl)-1-ethanone | 210832-85-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
151 | 1-(2-Pyridine)Benzylcyamide | 5005-36-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
152 | 3-Pyrrolidinepropanamide, α-amino-2-oxo-, hydrochloride | 2628280-48-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
153 | A-(P-TOLUENESULFONYL)-4-FLUOROBENZYLISONITRILE | 165806-95-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
154 | α-(4-chlorophenyl)pyridine-2-methanol | 27652-89-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
155 | Z-Val-nca | 158257-41-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
156 | WAY 100635 Hydrochloride | 146714-97-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
157 | TVT-2Sn | 477789-30-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
158 | Tubulysin B | 205304-87-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
159 | Tubastatin A HCl | 1310693-92-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
160 | tranylcypromine | 155-09-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
161 | Tris(4-(5-phenylthiophen-2-yl)phenyl)amine | 1092356-36-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
162 | Tolimidone | 41964-07-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
163 | Thalidomide-piperazine-Boc | 2222114-64-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
164 | Thalidomide-5,6-F | 1496997-41-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
165 | TGX-221 | 663619-89-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
166 | 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide | 934541-31-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
167 | TAK-788 | 1847461-43-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
168 | TAK-715 | 303162-79-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
169 | SU 6668 | 210644-62-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
170 | STATIL | 72702-95-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
171 | SQ 22,536 | 17318-31-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
172 | Seralutinib | 1619931-27-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
173 | tert-Butyl S-(4,6-dimethylpyrimidin-2-yl) thiolcarbonate | 41840-28-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
174 | SB202190; SB202190; SB 202190 | 152121-30-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
175 | (S)-(-)-1-(4-PYRIDYL)ETHANOL | 54656-96-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
176 | S-(Trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate | 129946-88-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
177 | Hexanoic acid,3-(aminomethyl)-5-methyl-, (3R)- | 148553-51-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
178 | Rho-Kinase-IN-1 | 1035094-83-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
179 | (R)-1-Boc-2-ethylPiperazine | 393781-70-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
180 | Quinidine Hydrochloride | 6151-40-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
181 | 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile | 1672668-24-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
182 | Pravadoline | 92623-83-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
183 | Boc-HPh-Leu-Phe-Ome | 868539-96-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
184 | 5-bromo-4-((2-ethylhexyl)oxy)thiophene-2-carbaldehyde | 2055812-54-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
185 | Nsc294729 | 27491-70-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
186 | O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromide | 200132-54-3 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
187 | Oncrasin 1 | 75629-57-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
188 | N-Acetyl-2-oxindole | 21905-78-2 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
189 | N-Acetylpiperazine | 13889-98-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
190 | N-Acetyl-L-thyroxineEthylEster | 30804-52-5 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
191 | N-Acetyl-3-Hydroxyindole | 33025-60-4 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
192 | N-Acetyl-DL-Tyrosine | 2901-77-1 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
193 | N-Ethyl-N-(4-Picolyl)-2-Phenylacrylamide | 57322-50-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
194 | N-Boc-Nortropinone | 185099-67-6 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
195 | 3-(Boc-amino)pyridine | 56700-70-0 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
196 | tert-Butyl-(3S)-3-hydroxypyrrolidin-1-carboxylate | 103057-44-9 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
197 | (S)-N-Boc-2-Hydroxymethylmorpholine | 135065-76-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
198 | N-tert-Butylpiperazine | 38216-72-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
199 | N-hydroxy-N'-(pyridin-3-yl)octanediamide | 382180-17-8 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |
200 | Benzeneacetamide, N-methoxy-N-methyl- | 95092-10-7 | pharmaceutical intermediates | Please send email to 13313091926@163.com to query | 2024-04-29 16:10:35 |